Clinical Trials Directory

Trials / Completed

CompletedNCT03507283

Vertical Split Conjunctival Autograft in Double-head Pterygia

Outcomes of Vertical Split Conjunctival Autograft Using Fibrin Glue in Treatment of Primary Double-head Pterygia

Status
Completed
Phase
Study type
Observational
Enrollment
15 (actual)
Sponsor
Benha University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

15 eyes of 15 patients with primary double-headed pterygia that underwent vertical split conjunctival autograft pterygium surgery were retrospectively reviewed. All patients had primary double-headed pterygia. Recurrence was defined as fibrovascular proliferation over the limbus onto the cornea. Vertical split conjunctival autograft using fibrin glue is an effective technique with good cosmetic results and low to no recurrence for primary double head pterygia treatment.

Detailed description

The pterygium body was dissected from the sclera. Complete excision of the pterygium, subconjunctival Tenon's tissue and surrounding fibrovascular tissues followed.The conjunctival edge was trimmed. The corneal surface was gently scraped with a scalpel. The Same procedure was done on temporal pterygia. A free conjunctival autograft was obtained. The graft was divided vertically into two parts. The nasal part of the graft was cut from limbal attachment including limbal tissue; temporal part was left attached. The nasal part of the graft was moved to the nasal conjunctival defect and attached to the sclera with fibrin sealant (Tisseel; Baxter, Vienna, Austria). The Same procedure was done with the temporal part of the graft. The orientation of graft was ensured before securing it.

Conditions

Interventions

TypeNameDescription
PROCEDUREDouble head pterygia excision and repairComplete excision of the pterygia was done. A free conjunctival autograft was obtained. The graft was divided vertically into two parts then secured into conjunctival defects.

Timeline

Start date
2011-04-01
Primary completion
2016-04-01
Completion
2016-08-01
First posted
2018-04-25
Last updated
2018-04-26

Source: ClinicalTrials.gov record NCT03507283. Inclusion in this directory is not an endorsement.